Evaluation of adherence to antiretroviral therapy for AIDS patients by Silva, Richardson Augusto Rosendo da et al.
www.ssoar.info
Evaluation of adherence to antiretroviral therapy for
AIDS patients
Silva, Richardson Augusto Rosendo da; Nelson, Ana Raquel Cortês; Duarte,
Fernando Hiago da Silva; Prado, Nanete Caroline da Costa; Holanda, Jose
Rebberty Rodrigo; Costa, Danyella Augusto Rosendo da Silva
Veröffentlichungsversion / Published Version
Zeitschriftenartikel / journal article
Empfohlene Zitierung / Suggested Citation:
Silva, R. A. R. d., Nelson, A. R. C., Duarte, F. H. d. S., Prado, N. C. d. C., Holanda, J. R. R., & Costa, D. A. R. d.
S. (2017). Evaluation of adherence to antiretroviral therapy for AIDS patients. Revista de Pesquisa: Cuidado é
Fundamental Online, 9(1), 15-20. https://doi.org/10.9789/2175-5361.2017.v9i1.15-20
Nutzungsbedingungen:
Dieser Text wird unter einer CC BY-NC Lizenz (Namensnennung-
Nicht-kommerziell) zur Verfügung gestellt. Nähere Auskünfte zu
den CC-Lizenzen finden Sie hier:
https://creativecommons.org/licenses/by-nc/4.0/deed.de
Terms of use:
This document is made available under a CC BY-NC Licence
(Attribution-NonCommercial). For more Information see:
https://creativecommons.org/licenses/by-nc/4.0
Diese Version ist zitierbar unter / This version is citable under:
https://nbn-resolving.org/urn:nbn:de:0168-ssoar-53583-3
CUIDADO É FUNDAMENTAL
UNIVERSIDADE FEDERAL DO ESTADO DO RIO DE JANEIRO . ESCOLA DE ENFERMAGEM ALFREDO PINTO
R E V I S T A  O N L I N E  D E  P E S Q U I S A
J. res.: fundam. care. online 2017. jan./mar. 9(1): 15-20
RESEARCH
CUIDADO É FUNDAMENTAL
UNIVERSIDADE FEDERAL DO ESTADO DO RIO DE JANEIRO . ESCOLA DE ENFERMAGEM ALFREDO PINTO
R E V I S T A  O N L I N E  D E  P E S Q U I S A
DOI: 10.9789/2175-5361.2017.v9i1.15-20
15
DOI: 10.9789/2175-5361.2017.v9i1.15-20  |  Galvão MCB; Davim RMB; Silva RAR  |  The experience of women in situations...
Avaliação da adesão à terapia antirretroviral em pacientes com AIDS
Evaluation of adherence to antiretroviral therapy for AIDS patients
Evaluación de la adherencia a la terapia antirretroviral en pacientes con SIDA
Richardson Augusto Rosendo da Silva1; Ana Raquel Cortês Nelson2; Fernando Hiago da Silva Duarte3; Nanete 
Caroline da Costa Prado4; Jose Rebberty Rodrigo Holanda5;Danyella Augusto Rosendo da Silva Costa6   
How to quote this article:
Silva RAR; Nelson ARC; Duarte FHS; et al. Evaluation of adherence to antiretroviral therapy for AIDS 
patients. Rev Fund Care Online. 2017 jan/mar; 9(1):15-20. DOI: http://dx.doi.org/10.9789/2175-5361.2017.
v9i1.15-20
ABSTRACT
Objective: The objective of the present study was to evaluate adherence to antiretroviral treatment for AIDS 
patients. Method: This is a quantitative study, field, and descriptive, at Reference Center for infectious diseases 
in Natal/RN, from August 2010 to July 2011. Data were collected through medical records, interviews and the 
pharmacy dispensing records. Results: Participated in the study 402 patients, among whom (70.2%) were male, 
the mean age was 35 years, and 90.0 had been diagnosed of HIV infection between 1 to 5 years. It was observed 
that 30% of the patients adhered to treatment. Conclusion: The Adherence in the present study are lower than 
those recommended in the literature, to increase adherence to ART is essential to carry out strategies to increase 
awareness and user engagement. 
Descriptors: Medication adherence; Antiretroviral therapy; HIV infections.
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RESUMO
Objetivo: Avaliar a adesão ao tratamento antirretroviral de pacientes 
com AIDS. Método: Trata-se de um estudo transversal e descritivo, com 
abordagem quantitativa realizado em um Centro de referência de doenças 
infectocontagiosas em Natal/RN, no período de agosto de 2010 a julho 
de 2011. Coletaram-se os dados por meio dos prontuários, questionário, 
e registro de dispensação da farmácia. Resultados: Dos 402 pacientes 
estudados, 70,2% eram do gênero masculino, com média de 35 anos, e 
90,0% apresentou tempo de contaminação de 1 a 5 anos. Observou-se 
que apenas 30% dos pacientes aderiram adequadamente ao tratamento. 
Conclusão: A adesão encontrada está aquém do preconizado na literatura, 
para aumentar a adesão à terapia antirretroviral (TARV) é indispensável 
a realização de estratégias de conscientização e envolvimento do usuário. 
Descritores: Adesão à medicação; Terapia antirretroviral de Alta 
atividade; Infecções por HIV. 
RESUMEN
Objetivo: Este estudio tuvo como objetivo evaluar la adherencia al 
tratamiento antirretroviral para pacientes con SIDA. Método: Estudio de 
carácter cuantitativo, campo, llevado a cabo en un centro de referencia 
para las enfermedades infecciosas en Natal/RN, de agosto 2010 a julio 
2011. Se recogieron los datos a través de gráficos, cuestionarios y registros 
de farmacia dispensadora. Resultados: De los 402 pacientes estudiados 
(70,2%) eran varones, con una media de 35 años, y el 90,0% mostraron 
contaminación momento 1-5 años. Se observó que el 30% de los pacientes 
se adhirió al tratamiento. Conclusión: La adherencia se encuentra más 
baja que las recomendadas en la literatura, para aumentar la adherencia 
al tratamiento antirretroviral es esencial para llevar a cabo las estrategias 
para aumentar el conocimiento y la participación de los usuarios. 
Descriptores: Cumplimiento de la medicación; Terapia antirretroviral 
Altamente activa; Infecciones por VIH.
INTRODUCTION
In the early 80s of last century, they began to identify the 
first cases of Acquired Immunodeficiency Syndrome (AIDS) 
in the world, and after more than two decades of the discovery 
of the human immunodeficiency virus (HIV), we still come 
across many challenges to understanding this epidemic.1
It is estimated that about 34 million (33.4 to 46 million) 
people worldwide are living with HIV. It is estimated also 
that 0.8% of adults aged 15-49 years worldwide living with 
this disease.2
In recent years, the availability of antiretroviral drugs 
has led to a significant decline in morbidity and mortality 
related to HIV/AIDS in Brazil and throughout the world. 
The resources available for treatment brings new challenges 
for understanding and coping with this disease.1
Thus, the emergence of antiretroviral therapy and access 
to treatment, had an impact on survival of HIV positive 
and became a disease considered highly lethal in a chronic 
nature of the disease, however, has not made AIDS a disease 
less of a concern.3
In Brazil, despite all the entrepreneurial activities 
developed by the National Program of Sexually Transmitted 
Diseases and AIDS in the last decade, a major public 
health problem and a new challenge have been reported: 
Treatment failure, mainly related by non-adherence patient 
to antiretroviral Therapy (HAART).4
The lack of adherence to new medicines for AIDS, 
particularly protease inhibitors (PI), is regarded as one of 
the most threatening risks for the effectiveness of treatment, 
at the individual level, and to the spread of virus resistance 
in the collective plane.3 This is because the new therapeutic 
regimens appear to require the individual to adhere to 
treatment, complex integration of knowledge, skills and 
acceptance, and other important factors related to the 
environment and care for the health.4
In the case of patients with HIV/AIDS who use HAART 
it is associated with treatment failure, when the membership 
is 80%.1 studies reinforce this finding, concluding that 
the desired maximum effects of antiretroviral treatment 
are obtained when reaches at least 95% adherence to the 
prescribed doses.5 
The extent of adherence to treatment for people with 
HIV can be done through various methods, among which 
include the self-report, questionnaires, with the use of 
electronic monitors, pill counts, records on the withdrawal 
of the pharmacy drugs and markers biological CD4 + 
T-lymphocytes and viral load (VL).1
The self-reporting is now considered the most common 
method used in the monitoring of adherence to treatment 
in patients with AIDS, since it has advantages for being a 
low-cost technique that requires little time to be applied, 
and provide listening and discussion about the reasons and 
difficulties relating to missed doses and possible solutions 
to improve adherence to treatment.1 Among the self-report, 
was created a multidimensional instrument of accession 
measure in Spain, called “Cuestionario para la Evaluación 
de la adhesión al Tratamiento Antiretroviral” (CEAT-HIV ).6 
This questionnaire has emerged as measure of adherence to 
treatment, specific to HIV/AIDS infection, and since 2007, 
when it was validated in Brazil, has been widely used in 
adhesion studies antiretroviral therapy, and therefore chosen 
as an instrument for this research.
To increase the effectiveness of the control of accession 
may be associated self-report method to control dispensing 
pharmacy. This measure is based on the possibility that 
patients seeking their medication at the right time are more 
likely to correctly take them than those who even delay in the 
removal of your medicines.1
Given this current picture of AIDS, it is believed to 
be necessary studies in this area on the part of health 
professionals, especially nurses, who are the primary 
caregivers of people getting sick. It is clear, at first, that 
the discussion of adherence to antiretroviral therapy is 
complex because it involves, directly or indirectly, various 
aspects, such as the biological, emotional, psychological, and 
especially the family, which it requires nurses comprehensive 
care and continues to this patient.
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Good adherence to therapy is therefore fundamental for 
the rehabilitation and stability of the patient with AIDS, this 
feeling, the existence of a public policy of universal access 
to antiretroviral medication in Brazil makes studies on 
adherence to ART are of great relevance to provide a better 
understanding of the problem and proper performance of 
the professional teams, to ensure good health and quality of 
life for people living with HIV/AIDS.6
This study was therefore aimed to assess adherence to 
antiretroviral treatment of AIDS patients.
METHOD
This is a descriptive study with a quantitative approach, 
performed in a reference center for the treatment of 
infectious diseases, located in northeastern Brazil. It was 
used as inclusion criteria for selection of the sample: Patients 
with AIDS, over 19 years, of both sexes, with clinical and 
cognitive conditions to answer the questions of the study 
instruments, who agreed to participate voluntarily signing 
Informed Consent and Informed (IC), and who were already 
on ART for at least one year. They were excluded from the 
study, those who refused to participate voluntarily or who 
dropped out during the process.
The sample was chosen randomly among those who 
attended the pharmacy for receiving antiretroviral (ARV), 
was calculated a probability sample from the number of 
registered patients at the pharmacy of their health service. 
For this, we used the calculation for finite populations 
with a sample error of 5% and the reliability of 95%, thus 
constituting up a sample of 402 participants. The data 
collection period was set from August 2010 to July 2011, 
estimated time to reach the required sample.
The self-reporting method through the Brazilian 
adaptation of “Cuestionario to her evaluación de la adhesión 
al antiretroviral tratamiento” and attendance in receiving 
ARV, were used to assess adherence to antiretroviral 
therapy. This instrument addresses issues that demonstrate 
reasons that could help or hinder adherence to treatment, 
such as stopped taking the drug to feel better, worse, sad or 
depressed? What relation has with the prescriber? Use some 
strategy to remember and/or facilitate the administration of 
the medicine? Do you have any difficulty taking the drugs? 
The occurrence of adverse reactions influences the non-
adherence to treatment? 
The total score in that instrument is obtained by the sum 
of all items (minimum value 17, maximum value 89). If the 
raw score is from 80 to 89 points, patient is considered as 
strictly adhered between 75 to 79 has good adherence to 
treatment and less than 74 is categorized as little adherence.7
Complementary to this instrument was used with 
permission of the interviewees, the records, the registration 
form of pharmacy and the Logistics Management System of 
Medicines (SICLOM)  of the Ministry of Health of Brazil.
The questionnaire was completed in the hospital, in a 
separate room, through interviews with patients coordinated 
by researchers. They were considered adherent patients 
who responded with optimistic and positive expectations 
regarding the treatment, who attended the pharmacy 
to receive ARVs every month during the survey period, 
which corresponded to score more than 74 points after the 
questionnaire evaluation.
The analysis of the information collected was performed 
using descriptive statistics with absolute frequencies 
and percentages.
The study was approved by the Ethics in Research of 
the Federal University of Rio Grande do Norte Committee 
under protocol number 129/2010 CAAE: 0146.0.051.000-10, 
and was funded by the Foundation will support research of 
Rio Grande do Norte (FAPERN).
RESULTS AND DISCUSSION
Sample characterization
As 12 patients did not meet the inclusion criteria and 
eight refused to participate in this research, amounted to a 
sample of 402 people. The average age was 35 years, ranging 
between 19 and 65 years of age. Males predominated by 
adding 70.2% of respondents.
When asked about the form of exposure to HIV, 
all claimed to have acquired the virus through sexual 
relations, their heterosexual majority. In relation to the 
time of infection, 90% had time of 1 to 5 years. In the group 
interviewed during the current treatment, 50% of patients 
used four ARV drugs and 40% of patients’ three ARV drugs.
Adherence to antiretroviral
In terms of age, it was found that 20% of patients aged 
30 to 40 years, had a total adherence to the treatment, which 
characterized the age group with the largest membership 
in the search. It was also observed that male patients had a 
larger membership (20%) compared to females (10%), and 
that the time of diagnosis was an influencer factor, since 
25% of patients in treatment, who attended the pharmacy 
every month, showed diagnosis time from 1 to 5 years, only 
5% of patients over 10 years of diagnosis regularly adhered 
to treatment.
Regarding the intensity of side effects due to HAART, 
50% of the patients considered the intense nothing, which 
has no side effects an obstacle to treatment adherence. In this 
context, 60% of respondents reported no difficulties to ingest 
the tablets and/or capsules, thus, the size of the tablets was 
not considered factor influencing nonadherence.
On the use of strategies to remember the medication 
time, 50% of respondents said they use some, such as services 
notes/phone tasks (15%), kitchen calendar (5%), warning 
in the refrigerator (10%), associated with the schedules of 
the meal (10%), family assistance (5%), and membership 
in the outward or return time work (5%). Regarding the 
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administration time, 50% reported that they are often used 
to take the medicine at the same time.
When asked about their opinion and conduct in relation 
to treatment, 62% of respondents considered themselves 
very doers of therapy. However, although they are considered 
loyal to treatment, only 30% of respondents attended every 
month for receiving ARV.
We observed a relationship between the drug regimen 
and adherence, as among patients who fully adhered 
therapy, 15% used: Lamivudine + Zidovudine and Efavirenz 
(AZT+3TC/EFZ) and 5% used: Fumarate, Lamivudine, 
atazanavir and ritonavir (TDF/3TC/ATV/RTV), showing 
that the amount of tablets can influence adherence, and 
prescription drugs can be combined an enabling strategy for 
compliance with therapy.
In this context, it was observed that 96% of patients 
reported having stopped taking the drug for ever forgetting 
or feel better, sad/depressed before the problems associated 
with the disease. While 96.6% reported having ever left to 
take a feel worse after the start of medication.
During the study period was possible to detect three 
cases of noncompliance, characterized by patients who only 
sought the pharmacy once the course of the research, which 
directly exemplifies the lack of adherence to ARV therapy.
And that because of the use of alcohol and the change 
of routine on weekends, 6% and 4% patients, respectively, 
reported not to use the drug during this period.
With regard to the relationship with the doctor, 90% of 
respondents said they maintain a good relationship as the 
infectious disease that meets 7% reported that this relationship 
can improve and 3% consider the relationship as regular.
It also contacted the information obtained from these 
patients on AIDS and ARV drugs still need to improve, 
as 50% of patients considered their unsatisfactory level of 
knowledge. The table 1 shows the measurement result of 
adherence to drug treatment, according to the results of 
CEAT-HIV test.
Table 1 – Compliance to drug treatment of HIV carriers, 
according to the results of the CEAT-HIV test
Adherence  Rating  n %
80-89 Stricted 48 12
75-79 Good 120 30
<74 Little 234 58
Total 402 100
                            
The analysis of this sample showed similar data to other 
research 8-9 regarding the predominant age group (between 
35 to 40 years), the prevalence of infection in males and the 
form of heterosexual transmission of the disease. Therefore, 
it is possible to observe a serious flaw with regard to the 
prevention of AIDS, due to the prevalence of transmission 
resulting from unprotected sex. These values  are consistent 
with another study, whose percentage found on this same 
form of HIV transmission was 64%.9
In relation to age, generally, adhesion increases with age, 
but above 75 years. Study shows an association between 
nonadherence and younger individuals as well as an increase 
in adhesion between more elderly individuals.6
It is worth noting that despite the prevalence of males, 
there is epidemiological trend of feminization of AIDS, 
mainly due to the increase in heterosexual transmission of 
HIV,8 fact also observed in this sample.
The treatment time is not a variable consensus in 
the literature regarding the higher prediction accession. 
Patients who are treated less time, is more likely to not 
adhere to treatment compared to patients who are treated 
for longer. This can be explained by the fact that patients 
become more committed to follow the treatment from 
the moment they realize gains in their clinical condition, 
according to the medication.9 In contrast, in this study, it 
was found that patients with time diagnostic one to five 
years have greater adhesion.
When dealing with drug therapy used, study reveals 
higher levels of adherence in patients using a maximum 
of three antiretroviral drugs (ARVs).10 Other research also 
shows that, for each ingested tablet, the risk increases to 
non-adherence by 12% and is 3.2 times every 10 tablets 
added in therapy.11 With technological advances made it 
possible to reduce number of daily pills, such as zidovudine 
and lamivudine combination (AZT+3TC) to facilitate 
adherence to treatment. The use of strategies to remember 
the medication time is also cited by patients in another study 
as a facilitator adhesion technique.12
The assessment of severity of side effects, a recent study 
conducted in the city of Toledo/PR showed that 42.3% of 
HAART users qualified as “nothing severe” side effects 
of therapy,12 values  close to those found in this sample. 
Research also shows that patients with HIV, more tolerate 
the side effects that patients with chronic illnesses less severe 
as hypertension or diabetes.13 Corroborating this result, in 
a Brazilian study, the authors found that the absence of side 
effects increased by 7.6 times the risk of nonadhesion.14
Regarding the self-evaluation of patients about their 
membership, there is a tendency of them overestimate their 
loyalty to treatment during the self-report technique or even 
evaluation questionnaires, the same fact was reported in the 
study previous1 and justified by the user’s fear disappoint or 
displease health professionals, which can be explained by the 
phenomenon of social desirability.
In this study, some patients reported discontinue 
treatment because drinking alcohol. Alcohol can reduce 
adhesion because many people can stop taking their 
medication because they felt intoxicated because they have 
drunk, and fail to take medications to fulfill their social 
functions such as going to parties and bars, where you 
are offered drinks.15 In in addition, alcohol can provide 
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risk behaviors such as use of other drugs and increase the 
frequency of depression.16
A study conducted in Marilia (SP) found that non-
adherent patients to antiretroviral therapy were 9.7 times 
more likely to stop taking the medication to drink alcohol 
than adherents, which corroborates the results found in 
this research.17
There is not yet defined relationship between sex and 
adherence to HAART, however, the literature indicates that 
women have higher numbers of absences from clinical and 
forget more often the medication doses than men, and this 
difference was explained by the fact that women need to 
manage family routines and child care, forgetting themselves. 
In addition, the same survey reveals that women tended two 
or more children are more compliant compared to that did 
not children.18
Regarding the affinity between the patient and the 
healthcare team, studies confirm the positive relationship 
between adherence and quality of care, especially the 
relationship with health.18 professionals This is considered 
essential to treatment adherence having regard to the 
customer’s perception of the competence of the professional, 
the quality and clarity of communication, the willingness of 
professionals to involve customers in decisions relating to 
the treatment, with the feeling of support, with satisfaction 
with staff and information suitable for the treatment and 
severity of side effects.
In this context, the high percentage of patients found in 
this study, with a poor knowledge about their clinical picture 
and therapy used, reflects a failure in the health service as 
the guidance and monitoring of the user. It is noteworthy, 
therefore, the fundamental role of staff to clarify and guide 
the patient regarding their clinical presentation, treatment, 
and all the issues surrounding his life from AIDS diagnosis.
Thus, the data obtained in this study showed a poor 
adherence to antiretroviral therapy among patients 
interviewed. This result is in line with other studies, 
governing the same subject from similar methodology.8.11 
In this context, it is clear that a multidisciplinary approach 
is grounded in the care of these patients in order to overcome 
the compartmentalized service, focused only on medical and 
clinical approach. The link established between the team and 
the user facilitates the monitoring and adherence to service, 
making the patient feel safe, respected and has the confidence 
to express their doubts related to living with HIV and AIDS.8
CONCLUSIONS
In the present study it was prevalent among respondents’ 
males, and the transmission profile of the disease by sex, 
heterosexual and unprotected.
Furthermore, it became apparent through the report of 
patients, combination therapy contributes to adherence to 
therapy, and patients and less time of diagnosis were more 
faithful to the regimen at the same time, the side effects could 
not be considered alone an influencer factor to low patient 
compliance to ARVs.
It is worth noting also the use of alcohol as a risk factor 
for non-adherence, and the good relationship with the 
doctor and the health team, as strong allies to continue the 
treatment and rehabilitation of patients with AIDS.
It can be concluded, therefore, that adherence found in 
this study is lower than those recommended in the literature 
to increase adherence to ART is essential that awareness 
strategies and user involvement are carried out, so that each 
patient recognizes the importance of following correctly the 
therapeutic regimen, linking directly a good adherence to a 
higher quality of life.
Regarding nursing, and the whole multidisciplinary team, 
we suggest the implementation of strategies for counseling 
the patient with AIDS, so that there is an increased awareness 
of each in relation to the disease, treatment and possible side 
effects, decreasing surprises and preparing each patient for 
effective membership.
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